- Home
- PCVX vs SLNO Comparison
PCVX vs SLNO Comparison
Compare PCVX & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | SLNO |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 2.5B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PCVX | SLNO |
|---|---|---|
| Price | $46.57 | $51.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $101.67 | ★ $110.90 |
| AVG Volume (30 Days) | 1.5M | ★ 1.8M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $98,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $155.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.66 | $41.50 |
| 52 Week High | $94.60 | $90.32 |
Technical Indicators
Market Signals| Indicator | PCVX | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 48.33 |
| Support Level | $43.78 | $47.80 |
| Resistance Level | $48.11 | $53.10 |
| Average True Range (ATR) | 1.99 | 2.47 |
| MACD | -0.49 | 1.09 |
| Stochastic Oscillator | 42.99 | 79.48 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.